Teladoc Health, Inc.

As of October 3, 2025, Teladoc Health, Inc. shows a mildly bullish technical trend supported by weekly and monthly indicators, but caution is advised due to mixed signals and poor long-term performance.

As of October 3, 2025, Teladoc Health, Inc. shows a mildly bullish trend supported by MACD, KST, and Dow Theory indicators, despite mixed signals from daily moving averages and varying performance against the S&P 500.

As of October 3, 2025, Teladoc Health, Inc. shows a mildly bullish technical trend, with weekly indicators supporting this stance despite daily moving averages indicating mild bearishness, while it has outperformed the S&P 500 in the past week and month but underperformed year-to-date.

As of September 19, 2025, Teladoc Health, Inc. shows a neutral technical trend with mixed indicators, having outperformed the S&P 500 recently but underperformed year-to-date.

As of September 19, 2025, Teladoc Health's technical trend is neutral with mixed signals, showing mild bullishness on MACD and KST but bearishness on moving averages, while it has outperformed the S&P 500 recently despite significant negative year-to-date returns.

As of September 10, 2025, Teladoc Health, Inc. is in a mildly bearish trend, underperforming the S&P 500 with a year-to-date return of -9.13% and a five-year return of -95.98%.

As of June 17, 2025, Teladoc Health, Inc. shows a mildly bearish trend, influenced by daily moving averages and Dow Theory, despite some mildly bullish indicators from the weekly MACD and KST.

As of March 2022, the management team of Teladoc Health, Inc. includes David Snow (Independent Chairman), Jason Gorevic (CEO), and directors Christopher Bischoff, Karen Daniel, Sandra Fenwick, Hemant Taneja, and Glen Tullman, who oversee the company's strategic direction and operations.

Teladoc Health, Inc. offers virtual healthcare services and is classified as a small-cap company with a market cap of approximately $1.24 billion. As of March 2025, it reported net sales of $629 million and a net loss of $93 million.

As of Jun 18, Teladoc Health, Inc. has a market capitalization of 1,242.08 million, with net sales of 2,552.81 million and a net profit of -1,012.37 million over the latest four quarters. The company reported shareholder's funds of 1,491.08 million and total assets of 3,763.36 million as of Dec 24.